It is a tricky one @Mounjour I am obviously with Oushk too at the moment.
My biggest (perceived as I haven't researched them thoroughly) concern with Livewell is they are one of the very new (to online WLI selling) kids on the block. Yes, they might (going by that MN poster!) give great, personalised service now, but they still have to go through the growth stage where they will need more prescribers, staff, more efficient processes to handle larger volume etc.
Oushk is far from perfect and their focus on social media and their "faithful" can be irritating, sometime entertaining, but they are further along navigating the challenges of that journey.
Then add in how Oushk are navigating the guidelines, they are being (perhaps naively) transparent in what they see as the GPhC issues and how they think they will handle them to make the GPhC happy. Remember the GPhC doesn't say to pharmacies clear rules like "you cannot prescribe below BMI 21", they give pharmacies a load of wooly guidelines about patient safety etc and pharmacies need to interpret them.
Oushk sharing one of the thing they are "thinking" about is not taking on new maintenance customers below BMI 25.5 might mean if (once I get there) there is no ability to move back if moving to a new provider (that hasn't been through a recent inspection yet) and it doesn't work out.
Anyone near maintenance, I think needs to think carefully about how they will play their hand as it may cut of future options, for now I personally think I am going to stick, keep my eyes open and see how this plays out over the next month or so of the enforcement notice. I could try another maintenance provider, but at the stage I am at, getting closing to maintenance I am thinking I might be better with the devil I know (plus I have a pen on hand and another preordered for the end of the month).
Good luck with your own decision!